FDAClass IIFebruary 11, 2026

Bisoprolol Fumarate and Hydrochlorothiazide tablets recall: Impurity Out of Spec

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD.…

Why was Bisoprolol Fumarate and Hydrochlorothiazide tablets recalled?

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # GBHL24005A, Exp Date: 09/2026

Product
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD.…
Recalling firm
Unichem Pharmaceuticals USA Inc.
Quantity
N/A
Distribution
US Nationwide and PR.
Recall date
February 11, 2026
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls